// company-profile
Outlook Therapeutics, Inc. Insider Trading
OTLKEvery SEC Form 4 insider trading filing for Outlook Therapeutics, Inc. (OTLK) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=OTLK" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bullish. Over the last 30 days, 3 insiders purchased shares (net $100K). Buying was led by Sukhtian Faisal Ghiath.
// 90-day insight
Over the last 90 days, Outlook Therapeutics, Inc. insiders bought $5.4M across 12 transactions with no open-market sales.
- Most active insider: Sukhtian Ghiath M. with 7 transactions totaling $5.0M.
- Largest single purchase: $5.0M by Sukhtian Ghiath M. on May 28, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Outlook Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Sukhtian Faisal Ghiath | OTLK | Purchase | 95,398 | $1.05 | $100K |
| Jul 21, 2026 | Jahr Robert Charles | OTLK | Award | 100,000 | $0.00 | $0K |
| Jul 21, 2026 | KENYON LAWRENCE A | OTLK | Award | 210,078 | $0.00 | $0K |
| Jun 2, 2026 | Haddadin Yezan Munther | OTLK | Purchase | 29,000 | $0.83 | $24K |
| May 28, 2026 | Sukhtian Ghiath M. | OTLK | H | 3,458,571 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →